The need for advanced biostatistics services and efficient clinical development strategies to shorten timelines, reduce costs and risks, and improve the quality of submissions is vital. State-of-the-art statistical methods play a key role in every step of the drug development process. We believe that the most efficient and cost-effective way to conduct and control clinical trials is to make the best possible use of advanced and innovative statistical methodology.